Literature DB >> 6609028

Oral contraceptive agents do not affect serum prolactin in normal women.

J R Davis, C Selby, W J Jeffcoate.   

Abstract

A total of 230 healthy women attending family planning clinics took part in a cross-sectional study, comparing contraceptive histories and serum prolactin levels. It was found that the distribution histogram of serum prolactin was markedly skewed to the right in all main groups, but that the distribution profile was not affected by use of oestrogen-containing contraceptives. Neither the dose of oestrogens nor duration of their use affected prolactin levels. We have thus found that currently available combined oral contraceptive agents have no effect on serum prolactin. Analysis of the skewed raw data yields a 'normal' range of 110-700 mU/l, higher than that usually accepted.

Entities:  

Keywords:  Age Factors; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods--side effects; Cross Sectional Analysis; Endocrine System; Family Planning; Gonadotropins; Gonadotropins, Pituitary; Hormones; Oral Contraceptives--side effects; Physiology; Pituitary Hormones; Prolactin--analysis; Reproductive Control Agents; Research Methodology; Sampling Studies; Studies; Surveys

Mesh:

Substances:

Year:  1984        PMID: 6609028     DOI: 10.1111/j.1365-2265.1984.tb03438.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  10 in total

Review 1.  Pharmacologic resistance in prolactinoma patients.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy.

Authors:  D H Barlow; G H Beastall; H I Abdalla; J Elias-Jones; R Lindsay; D M Hart
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-23

Review 3.  Prolactinomas.

Authors:  A Grossman; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

Review 5.  PRL-secreting pituitary adenomas in pregnancy.

Authors:  I Chiodini; A Liuzzi
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

6.  Prolactin response to low dose sulpiride.

Authors:  M E McMurdo; P W Howie; M Lewis; M Marnie; J McEwen; A S McNeilly
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

Review 7.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 8.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 9.  Pituitary tumors. Current concepts in diagnosis and management.

Authors:  D C Aron; J B Tyrrell; C B Wilson
Journal:  West J Med       Date:  1995-04

10.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.